Frank Karbe

Insider Reports History

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, 9 Th Floor, Brisbane, CA
Signature
/s/ Shane Ward, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Karbe:

Insider Reports Filed by Frank Karbe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDTX Cidara Therapeutics, Inc. Feb 24, 2025 2 $0 4 Feb 26, 2025 Chief Financial Officer
CDTX Cidara Therapeutics, Inc. Feb 24, 2025 0 $0 3 Feb 26, 2025 Chief Financial Officer
PHAT Phathom Pharmaceuticals, Inc. Dec 13, 2024 1 $99.1K 4 Dec 16, 2024 Director
PHAT Phathom Pharmaceuticals, Inc. May 29, 2024 1 $254K 4 May 31, 2024 Director
PHAT Phathom Pharmaceuticals, Inc. May 23, 2024 2 $0 4 May 24, 2024 Director
BTTX Better Therapeutics, Inc. Dec 18, 2023 1 $0 4 Dec 20, 2023 Chief Executive Officer, Director
BTTX Better Therapeutics, Inc. Jul 27, 2023 1 $100K 4 Jul 31, 2023 Chief Executive Officer, Director
PHAT Phathom Pharmaceuticals, Inc. May 25, 2023 2 $0 4 May 30, 2023 Director
BTTX Better Therapeutics, Inc. Apr 10, 2023 1 $200K 4 Apr 12, 2023 Chief Executive Officer, President, Treasurer and Secretary, Director
BTTX Better Therapeutics, Inc. Sep 15, 2022 1 $105K 4 Sep 15, 2022 Chief Executive Officer, President, Treasurer and Secretary, Director
BTTX Better Therapeutics, Inc. Jul 5, 2022 1 $0 4 Jul 7, 2022 Chief Executive Officer, President, Treasurer and Secretary, Director
BTTX Better Therapeutics, Inc. Jul 5, 2022 0 $0 3 Jul 7, 2022 Chief Executive Officer, President, Treasurer and Secretary. Exhibit 24 - Power of Attorney., Director
PHAT Phathom Pharmaceuticals, Inc. May 25, 2022 1 $0 4 May 27, 2022 Director
PHAT Phathom Pharmaceuticals, Inc. Apr 25, 2022 1 $0 4 Apr 26, 2022 Director
PHAT Phathom Pharmaceuticals, Inc. Apr 25, 2022 0 $0 3 Apr 26, 2022 Director
MYOV Myovant Sciences Ltd. Jul 7, 2021 1 -$70.3K 4 Jul 9, 2021 Principal Fin'l & Accounting